⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31246021 | 0.79 | UTS2R (0.35) | — | |
| SCHEMBL31245971 | 0.73 | BRD4 (0.48) | — | |
| SCHEMBL31246014 | 0.68 | BRD4 (0.42) | — | |
| SCHEMBL30824826 | 0.61 | UTS2R (0.34) | — | |
| SCHEMBL27391581 | 0.61 | UTS2R (0.34) | — | |
| SCHEMBL24319841 | 0.61 | ALDH1A1 (0.35) | — | |
| SCHEMBL30824784 | 0.61 | BRD4 (0.51) | — | |
| SCHEMBL27391659 | 0.61 | BRD4 (0.51) | — | |
| SCHEMBL30812291 | 0.54 | ALDH1A1 (0.36) | — | |
| SCHEMBL30812271 | 0.54 | ALDH1A1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702022-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | Halda Therapeutics Opco, Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024211684-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-10-10 | — | — | WO | disclosed |